Long-Acting Drugs May Revolutionize H.I.V. Prevention and Treatment
New regimens in development, including once-weekly pills and semiannual shots, [...]
10 Charged in $20 Million Scheme to Sell Black-Market H.I.V. Drugs
Federal prosecutors said the defendants encouraged low-income patients to sell [...]
PEPFAR Turned the Tide of AIDS and It’s Now at Risk
In 2003, President Bush started PEPFAR to fight AIDS. But [...]
Why One Drug Company Held Back a Better Drug
Drug companies say patents spur innovation. Can they also do [...]
Expert Panel Recommends New Drugs for HIV Prevention
The “grade A” endorsement means that two additional drugs should [...]
How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy
Gilead delayed a new version of a drug, allowing it [...]
When Politics Saves Lives: a Good-News Story
The decision to fund medications to treat H.I.V.-AIDS patients in [...]
Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEP
A jury sided with Gilead Sciences in a dispute over [...]
The Only H.I.V. Vaccine in Advanced Trials Has Failed. What Now?
Janssen Pharmaceuticals ended a global trial after independent experts determined [...]
How Anthony Fauci Quietly Shocked AIDS Activists
An ACT UP veteran remembers the doctor’s AIDS legacy.